NervGen Pharma Corp. Common stock (NGEN) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for NervGen Pharma Corp. Common stock, updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$1.50
+1.35% today
Market cap
$159M
Overall quality
—
Kronos AI 30-day
+21.7%
8 of 8 simulated paths end higher
NervGen Pharma Corp. Common stock (NGEN) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $159M. It trades at $1.50, up 1.35% today. 2 analysts' average target of $10.00 implies +566.7% from today's price. Kronos AI's 30-day forecast is +21.7% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $10.00 |
| Low – high | $10.00 – $10.00 |
| Analysts | 2 |
| Upside to average | +566.7% |
Kronos AI 30-day forecast
| Expected close | $1.80 (+21.7%) |
| Likely range | +13.3% … +27.3% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.